Professional Documents
Culture Documents
Uv-Vis Spectra A-B
Uv-Vis Spectra A-B
Uv-Vis Spectra A-B
REFERENCE SPECTRA
The ultraviolet-visible reference spectra presented here were obtained by the use of double-
beam spectrophotometers with sample solutions prepared as specified in the individual
monographs. The horizontal axis indicates the wavelength (nm) and the vertical axis indi-
cates the absorbance.
JP XVII Ultraviolet-visible Reference Spectra 2225
Acebutolol Hydrochloride
Acemetacin
Acetohexamide 1
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2226 Ultraviolet-visible Reference Spectra JP XVII
Acetohexamide 2
Aciclovir
Aclarubicin Hydrochloride
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVII Ultraviolet-visible Reference Spectra 2227
Acrinol Hydrate
Actinomycin D
Adrenaline
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2228 Ultraviolet-visible Reference Spectra JP XVII
Afloqualone
Alimemazine Tartrate
Allopurinol
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVII Ultraviolet-visible Reference Spectra 2229
Alminoprofen
Alprazolam
Alprenolol Hydrochloride
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2230 Ultraviolet-visible Reference Spectra JP XVII
Alprostadil
Alprostadil Alfadex
Ambenonium Chloride
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVII Ultraviolet-visible Reference Spectra 2231
Amiodarone Hydrochloride
Amitriptyline Hydrochloride
Amlexanox
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2232 Ultraviolet-visible Reference Spectra JP XVII
Amlodipine Besilate
Amosulalol Hydrochloride
Amoxapine
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVII Ultraviolet-visible Reference Spectra 2233
Amphotericin B
Ampiroxicam
Aprindine Hydrochloride
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2234 Ultraviolet-visible Reference Spectra JP XVII
Argatroban Hydrate
Arotinolol Hydrochloride
Aspoxicillin Hydrate
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVII Ultraviolet-visible Reference Spectra 2235
Atenolol
Azathioprine
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2236 Ultraviolet-visible Reference Spectra JP XVII
Azelastine Hydrochloride
Azelnidipine
Aztreonam
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVII Ultraviolet-visible Reference Spectra 2237
Bacampicillin Hydrochloride
Baclofen
Bamethan Sulfate
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2238 Ultraviolet-visible Reference Spectra JP XVII
Benidipine Hydrochloride
Benserazide Hydrochloride
Benzalkonium Chloride
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVII Ultraviolet-visible Reference Spectra 2239
Benzbromarone
Benzethonium Chloride
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2240 Ultraviolet-visible Reference Spectra JP XVII
Benzylpenicillin Potassium
Bepotastine Besilate
Beraprost Sodium
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVII Ultraviolet-visible Reference Spectra 2241
Berberine Tannate
Betahistine Mesilate
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2242 Ultraviolet-visible Reference Spectra JP XVII
Betamethasone
Betamethasone Dipropionate
Betamipron
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVII Ultraviolet-visible Reference Spectra 2243
Betaxolol Hydrochloride
Bezafibrate
Bifonazole
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2244 Ultraviolet-visible Reference Spectra JP XVII
Biperiden Hydrochloride
Bisacodyl
Bisoprolol Fumarate
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVII Ultraviolet-visible Reference Spectra 2245
Bleomycin Hydrochloride
Bleomycin Sulfate
Bromazepam
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2246 Ultraviolet-visible Reference Spectra JP XVII
Bromhexine Hydrochloride
Bromocriptine Mesilate
Brotizolam
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVII Ultraviolet-visible Reference Spectra 2247
Bucumolol Hydrochloride
Bufetolol Hydrochloride
Buformin Hydrochloride
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2248 Ultraviolet-visible Reference Spectra JP XVII
Bumetanide
Bupranolol Hydrochloride
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
JP XVII Ultraviolet-visible Reference Spectra 2249
Buprenorphine Hydrochloride
Butenafine Hydrochloride
Butropium Bromide 1
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)
2250 Ultraviolet-visible Reference Spectra JP XVII
Butropium Bromide 2
Cadralazine
Calcitonin Salmon
The JP Drugs are to be tested according to the provisions given in the pertinent monographs, General Notices, General Rules for Crude Drugs,
General Rules for Preparations, and General Tests for their conformity to the Japanese Pharmacopoeia. (See the General Notices 5.)